<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04852237</url>
  </required_header>
  <id_info>
    <org_study_id>1916</org_study_id>
    <nct_id>NCT04852237</nct_id>
  </id_info>
  <brief_title>Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?</brief_title>
  <official_title>Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes? A 10 Years Single-center Experience Comparing ICSI-TESE Pregnancies From ICSI Pregnancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine if the lack of exposure to sperm antigens is&#xD;
      associated with worse maternal and neonatal outcomes in pregnancies obtained after ICSI&#xD;
      (intracytoplasmic sperm injection)-TESE (testicular sperm extraction) for obstructive&#xD;
      azoospermia.&#xD;
&#xD;
      The primary outcomes that will be investigated include:&#xD;
&#xD;
        -  Maternal outcomes: live birth rate (LBR), abortion rate, and the rate of the main&#xD;
           obstetrics complication, such as pre-eclampsia, gestational hypertension and diabetes&#xD;
           mellitus.&#xD;
&#xD;
        -  Neonatal outcomes: gestational age, prematurity rate, birth weight, sex ratio, 1- and&#xD;
           5-min APGAR, birth defects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies investigated the role of paternal factors in the development of preeclampsia;&#xD;
      in particular, they analyzed the correlation between the vaginal exposure to male partner's&#xD;
      semen and the incidence of preeclampsia, observing both a reduced risk of preeclampsia after&#xD;
      prolonged exposure to the paternal seminal fluid and a higher incidence of preeclampsia in&#xD;
      pregnancies conceived with a new father or with sperm donor. This leads to the hypothesis of&#xD;
      an immunological role for sperm in inducing a mucosal immune tolerance-like status at the&#xD;
      level of the uterus that could be critical in the subsequent implantation.&#xD;
&#xD;
      Previous studies also examined the neonatal outcomes from pregnancies obtained from&#xD;
      surgically retrieved sperm, either epididymal or testicular sperm, and underlined that there&#xD;
      is not overall increased risk in neonatal outcomes.&#xD;
&#xD;
      Our study aims at having a complete view on paternal, maternal and neonatal information and a&#xD;
      follow up, that allows to correct possible confounders and to analyze a wider group of&#xD;
      outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate (LBR)</measure>
    <time_frame>10 years</time_frame>
    <description>Rate of delivery of a living baby after at least 22 weeks of gestation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Abortion Rate (AR)</measure>
    <time_frame>10 years</time_frame>
    <description>Proportion of clinical pregnancies who failed to continue beyond 22 weeks of gestation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal complications rate</measure>
    <time_frame>10 years</time_frame>
    <description>Incidence of the obstetric complications, such as pre-eclampsia, gestational hypertension and diabetes, placenta previa and placental abruption.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gestational age</measure>
    <time_frame>10 years</time_frame>
    <description>Mean gestational age of the pregnancies considered (written with both weeks and days; eg, 39 weeks and 0 days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prematurity rate</measure>
    <time_frame>10 years</time_frame>
    <description>Rate of pregnancies lasted less than 37 weeks and 0 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Birth weight</measure>
    <time_frame>10 years</time_frame>
    <description>Mean birth weight of the neonates, written in grams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex ratio</measure>
    <time_frame>10 years</time_frame>
    <description>Ratio between males and females among the newborns</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1- and 5-min APGAR</measure>
    <time_frame>10 years</time_frame>
    <description>Objective score of the condition of a baby after birth, at 1 and 5 minutes from the delivery (from 1 to 10 points).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of congenital defects</measure>
    <time_frame>10 years</time_frame>
    <description>Incidence of congenital malformations, deformations and chromosomal abnormalities among the newborns of the study group (eg. clubfoot deformity, anorectal malformations, heart defects, ...)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">400</enrollment>
  <condition>Obstructive Azoospermia</condition>
  <condition>Obstetric Complication</condition>
  <arm_group>
    <arm_group_label>Pregnancies from ICSI-TESE cycles for obstructive azoospermia.</arm_group_label>
    <description>Pregnancies occurred between January 2010 and December 2019 at Humanitas Fertility Center after ICSI-TESE cycles for obstructive azoospermia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnancies from ICSI cycles with ejaculated sperm.</arm_group_label>
    <description>Pregnancies occurred between January 2010 and December 2019 at Humanitas Fertility Center after ICSI cycles with ejaculated sperm.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study database will include all the pregnancies occurred between January 2010 and&#xD;
        December 2019 at Humanitas Fertility Center after ICSI-TESE cycles for obstructive&#xD;
        azoospermia.&#xD;
&#xD;
        A comparison of maternal and neonatal outcomes will be performed among the above-mentioned&#xD;
        pregnancies and pregnancies from ICSI cycles with ejaculated sperm of couples with&#xD;
        different indications occurred in the same period of time.&#xD;
&#xD;
        The controls will be matched to the cases for the principal risk factors for adverse&#xD;
        maternal and neonatal outcomes (maternal age, BMI) with a ratio of 1:2.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for case arm:&#xD;
&#xD;
          -  primary infertility&#xD;
&#xD;
          -  diagnosis of obstructive azoospermia&#xD;
&#xD;
          -  ICSI-TESE cycles&#xD;
&#xD;
        Inclusion Criteria for control arm:&#xD;
&#xD;
          -  primary infertility&#xD;
&#xD;
          -  ICSI cycles with sperm from ejaculate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pre-gestational hypertension&#xD;
&#xD;
          -  pre-gestational diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
  </eligibility>
  <reference>
    <citation>Robertson SA, Sharkey DJ. Seminal fluid and fertility in women. Fertil Steril. 2016 Sep 1;106(3):511-9. doi: 10.1016/j.fertnstert.2016.07.1101. Epub 2016 Jul 30. Review.</citation>
    <PMID>27485480</PMID>
  </reference>
  <reference>
    <citation>Verwoerd GR, Hall DR, Grov√© D, Maritz JS, Odendaal HJ. Primipaternity and duration of exposure to sperm antigens as risk factors for pre-eclampsia. Int J Gynaecol Obstet. 2002 Aug;78(2):121-6.</citation>
    <PMID>12175712</PMID>
  </reference>
  <reference>
    <citation>Wang JX, Knottnerus AM, Schuit G, Norman RJ, Chan A, Dekker GA. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet. 2002 Feb 23;359(9307):673-4.</citation>
    <PMID>11879865</PMID>
  </reference>
  <reference>
    <citation>Di Mascio D, Saccone G, Bellussi F, Vitagliano A, Berghella V. Type of paternal sperm exposure before pregnancy and the risk of preeclampsia: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2020 Aug;251:246-253. doi: 10.1016/j.ejogrb.2020.05.065. Epub 2020 Jun 1. Review.</citation>
    <PMID>32544753</PMID>
  </reference>
  <reference>
    <citation>Dekker G, Robillard PY, Roberts C. The etiology of preeclampsia: the role of the father. J Reprod Immunol. 2011 May;89(2):126-32. doi: 10.1016/j.jri.2010.12.010. Epub 2011 May 6. Review.</citation>
    <PMID>21529966</PMID>
  </reference>
  <reference>
    <citation>Andraweera P, Roberts CT, Leemaqz S, McCowan L, Myers J, Kenny LC, Walker J, Poston L, Dekker G; SCOPE Consortium. The duration of sexual relationship and its effects on adverse pregnancy outcomes. J Reprod Immunol. 2018 Aug;128:16-22. doi: 10.1016/j.jri.2018.05.007. Epub 2018 May 18.</citation>
    <PMID>29803191</PMID>
  </reference>
  <reference>
    <citation>Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA. 1989 Dec 8;262(22):3143-7.</citation>
    <PMID>2810672</PMID>
  </reference>
  <reference>
    <citation>Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. J Reprod Immunol. 2011 May;89(2):104-17. doi: 10.1016/j.jri.2011.02.003. Epub 2011 May 4. Review.</citation>
    <PMID>21543120</PMID>
  </reference>
  <reference>
    <citation>Jin L, Li Z, Gu L, Huang B. Neonatal outcome of children born after ICSI with epididymal or testicular sperm: A 10-year study in China. Sci Rep. 2020 Mar 20;10(1):5145. doi: 10.1038/s41598-020-62102-y.</citation>
    <PMID>32198466</PMID>
  </reference>
  <reference>
    <citation>Belva F, De Schrijver F, Tournaye H, Liebaers I, Devroey P, Haentjens P, Bonduelle M. Neonatal outcome of 724 children born after ICSI using non-ejaculated sperm. Hum Reprod. 2011 Jul;26(7):1752-8. doi: 10.1093/humrep/der121. Epub 2011 Apr 21.</citation>
    <PMID>21511713</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>April 20, 2021</last_update_submitted>
  <last_update_submitted_qc>April 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neonatal outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

